Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Author:

Tutt Andrew N.J.1ORCID,Garber Judy E.1,Kaufman Bella1,Viale Giuseppe1,Fumagalli Debora1,Rastogi Priya1,Gelber Richard D.1,de Azambuja Evandro1ORCID,Fielding Anitra1,Balmaña Judith1,Domchek Susan M.1,Gelmon Karen A.1,Hollingsworth Simon J.1,Korde Larissa A.1,Linderholm Barbro1,Bandos Hanna1,Senkus Elżbieta1,Suga Jennifer M.1,Shao Zhimin1,Pippas Andrew W.1,Nowecki Zbigniew1,Huzarski Tomasz1,Ganz Patricia A.1,Lucas Peter C.1,Baker Nigel1,Loibl Sibylle1,McConnell Robin1,Piccart Martine1,Schmutzler Rita1,Steger Guenther G.1,Costantino Joseph P.1,Arahmani Amal1,Wolmark Norman1,McFadden Eleanor1,Karantza Vassiliki1,Lakhani Sunil R.1,Yothers Greg1,Campbell Christine1,Geyer Charles E.1ORCID

Affiliation:

1. From the Breast Cancer Now Toby Robins Research Centre, the Institute of Cancer Research (A.N.J.T.), and the Breast Cancer Now Unit, Guy’s Hospital Cancer Centre, King’s College London (A.N.J.T.), London, AstraZeneca, Cambridge (S.J.H., N.B.), and Frontier Science (Scotland), Kincraig (R.M.C., E.M.F., C.C.) — all in the United Kingdom; Dana–Farber Cancer Institute, Harvard Medical School (J.E.G., R.D.G.), Frontier Science Foundation (R.D.G.), and Harvard T.H. Chan School of Public Health (R.D.G.) — all...

Funder

AstraZeneca

Merck Sharp and Dohme

US National Cancer Institute

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3